News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,724 Results
Type
Article (47786)
Company Profile (330)
Press Release (694592)
Multimedia
Podcasts (117)
Webinars (18)
Section
Business (209659)
Career Advice (2248)
Deals (36446)
Drug Delivery (124)
Drug Development (83012)
Employer Resources (178)
FDA (16593)
Job Trends (15341)
News (354361)
Policy (33430)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2603)
Accelerated approval (32)
Adcomms (29)
Allergies (139)
Alliances (51130)
ALS (178)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (324)
Approvals (16824)
Artificial intelligence (533)
Autoimmune disease (153)
Automation (37)
Bankruptcy (372)
Best Places to Work (11734)
BIOSECURE Act (21)
Biosimilars (190)
Biotechnology (225)
Bladder cancer (159)
Brain cancer (59)
Breast cancer (640)
Cancer (4876)
Cardiovascular disease (416)
Career advice (1887)
Career pathing (37)
CAR-T (294)
CDC (46)
Celiac Disease (2)
Cell therapy (780)
Cervical cancer (36)
Clinical research (70747)
Collaboration (1772)
Company closure (4)
Compensation (1159)
Complete response letters (63)
COVID-19 (2762)
CRISPR (96)
C-suite (851)
Cystic fibrosis (147)
Data (6242)
Decentralized trials (2)
Denatured (35)
Depression (140)
Diabetes (500)
Diagnostics (6745)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (253)
Drug pricing (195)
Drug shortages (28)
Duchenne muscular dystrophy (235)
Earnings (90987)
Editorial (58)
Employer branding (21)
Employer resources (158)
Events (121224)
Executive appointments (989)
FDA (19717)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1504)
Gene editing (209)
Generative AI (46)
Gene therapy (639)
GLP-1 (1005)
Government (4722)
Grass and pollen (6)
Guidances (384)
Healthcare (19014)
HIV (56)
Huntington's disease (49)
IgA nephropathy (83)
Immunology and inflammation (271)
Immuno-oncology (61)
Indications (105)
Infectious disease (3031)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (247)
Interviews (360)
IPO (16961)
IRA (51)
Job creations (3942)
Job search strategy (1595)
JPM (65)
Kidney cancer (16)
Labor market (84)
Layoffs (580)
Leadership (36)
Legal (8161)
Liver cancer (92)
Longevity (15)
Lung cancer (647)
Lymphoma (379)
Machine learning (44)
Management (62)
Manufacturing (810)
MASH (165)
Medical device (13804)
Medtech (13856)
Mergers & acquisitions (20547)
Metabolic disorders (1299)
Multiple sclerosis (162)
NASH (18)
Neurodegenerative disease (331)
Neuropsychiatric disorders (92)
Neuroscience (2962)
Neurotech (1)
NextGen: Class of 2026 (6687)
Non-profit (4557)
Now hiring (66)
Obesity (618)
Opinion (304)
Ovarian cancer (165)
Pain (206)
Pancreatic cancer (229)
Parkinson's disease (286)
Partnered (34)
Patents (494)
Patient recruitment (480)
Peanut (56)
People (60578)
Pharmaceutical (68)
Pharmacy benefit managers (29)
Phase 1 (22173)
Phase 2 (31183)
Phase 3 (23095)
Pipeline (5173)
Policy (296)
Postmarket research (2588)
Preclinical (9400)
Press Release (72)
Prostate cancer (236)
Psychedelics (53)
Radiopharmaceuticals (282)
Rare diseases (874)
Real estate (6313)
Recruiting (72)
Regulatory (24974)
Reports (51)
Research institute (2442)
Resumes & cover letters (378)
Rett syndrome (28)
RNA editing (18)
RSV (78)
Schizophrenia (150)
Series A (255)
Series B (197)
Service/supplier (13)
Sickle cell disease (102)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3876)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (89)
The Weekly (80)
Vaccines (1030)
Venture capital (96)
Weight loss (402)
Women's health (87)
Worklife (20)
Date
Today (59)
Last 7 days (607)
Last 30 days (2061)
Last 365 days (30616)
2026 (2959)
2025 (31014)
2024 (36000)
2023 (40711)
2022 (51904)
2021 (56378)
2020 (54699)
2019 (47159)
2018 (35603)
2017 (33152)
2016 (32601)
2015 (38467)
2014 (33847)
2013 (28963)
2012 (29451)
2011 (30121)
2010 (28200)
Location
Africa (819)
Alabama (84)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (41272)
Australia (6918)
California (11328)
Canada (3273)
China (1133)
Colorado (477)
Connecticut (476)
Delaware (334)
Europe (90239)
Florida (1672)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (882)
India (63)
Indiana (519)
Iowa (23)
Japan (427)
Kansas (130)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1392)
Massachusetts (8171)
Michigan (321)
Minnesota (636)
Mississippi (5)
Missouri (127)
Montana (34)
Nebraska (29)
Nevada (122)
New Hampshire (79)
New Jersey (3029)
New Mexico (29)
New York (2991)
North Carolina (1484)
North Dakota (9)
Northern California (5522)
Ohio (330)
Oklahoma (22)
Oregon (41)
Pennsylvania (2281)
Puerto Rico (22)
Rhode Island (47)
South America (1201)
South Carolina (65)
South Dakota (1)
Southern California (4393)
Tennessee (172)
Texas (1745)
United States (40257)
Utah (341)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (936)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
742,724 Results for "oncolytics biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncolytics Biotech® Announces Results of Special Meeting of Shareholders
January 16, 2026
·
3 min read
Press Releases
Oncolytics Biotech® Provides Update on Intellectual Property Strategy and Patent Filings
January 9, 2026
·
4 min read
Press Releases
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
January 15, 2026
·
5 min read
Press Releases
Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer
February 5, 2026
·
6 min read
Press Releases
Oncolytics Biotech® Provides Update on Special Meeting of Shareholders
November 21, 2025
·
3 min read
Press Releases
Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer
December 17, 2025
·
6 min read
Press Releases
Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer
January 13, 2026
·
5 min read
Press Releases
Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer
November 20, 2025
·
5 min read
Press Releases
Oncolytics Biotech® Expands Its Gastrointestinal Tumor Scientific Advisory Board with the Addition of Dr. Eileen O’Reilly, Dr. Neil Segal, and Dr. Van Morris
January 8, 2026
·
7 min read
Press Releases
Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy
November 5, 2025
·
5 min read
1 of 74,273
Next
